Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Infect Control Hosp Epidemiol ; 45(4): 526-529, 2024 Apr.
Article in English | MEDLINE | ID: mdl-37700531

ABSTRACT

We investigated whether and how infection prevention programs monitor for health disparities as part of healthcare-associated infection (HAI) surveillance through a survey of healthcare epidemiology leaders. Most facilities are not assessing for disparities in HAI rates. Professional society and national guidance should focus on addressing this gap.


Subject(s)
Cross Infection , Humans , Cross Infection/epidemiology , Cross Infection/prevention & control , Surveys and Questionnaires , Health Facilities , Delivery of Health Care , Health Inequities , Infection Control
6.
Clin Rev Allergy Immunol ; 50(2): 214-27, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26690368

ABSTRACT

First described by Paul Ehrlich in 1879, who noted its characteristic staining by acidophilic dyes, for many years, the eosinophil was considered to be an end-effector cell associated with helminth infections and a cause of tissue damage. Over the past 30 years, research has helped to elucidate the complexity of the eosinophil's function and establish its role in host defense and immunity. Eosinophils express an array of ligand receptors which play a role in cell growth, adhesion, chemotaxis, degranulation, and cell-to-cell interactions. They play a role in activation of complement via both classical and alternative pathways. Eosinophils synthesize, store and secrete cytokines, chemokines, and growth factors. They can process antigen, stimulate T cells, and promote humoral responses by interacting with B cells. Eosinophils can function as antigen presenting cells and can regulate processes associated with both T1 and T2 immunity. Although long known to play a role in defense against helminth organisms, the interactions of eosinophils with these parasites are now recognized to be much more complex. In addition, their interaction with other pathogens continues to be investigated. In this paper, we review the eosinophil's unique biology and structure, including its characteristic granules and the effects of its proteins, our developing understanding of its role in innate and adaptive immunity and importance in immunomodulation, and the part it plays in defense against parasitic, viral, fungal and bacterial infections. Rather than our worst enemy, the eosinophil may, in fact, be one of the most essential components in host defense and immunity.


Subject(s)
Eosinophils/pathology , Infections/etiology , Infections/pathology , Adaptive Immunity , Animals , Cell Differentiation , Chemotaxis/immunology , Cytokines/metabolism , Eosinophils/cytology , Eosinophils/immunology , Eosinophils/metabolism , Humans , Immunity, Innate , Infections/metabolism , Inflammation Mediators/metabolism , Membrane Proteins/metabolism
8.
Pediatrics ; 119(4): e1002-5, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17353300

ABSTRACT

Mycoplasma pneumoniae is a common cause of community-acquired respiratory illness in the adolescent population. Stevens-Johnson syndrome is an extrapulmonary manifestation that has been associated with M. pneumoniae infections. Three adolescent males presented within a 1-month period with M. pneumoniae respiratory illnesses and severe mucositis but without the classic rash typical of Stevens-Johnson. Diagnosis was facilitated by the use of a polymerase chain reaction-based assay. This case series highlights the potential for M. pneumoniae-associated Stevens-Johnson syndrome to occur without rash and supports the use of polymerase chain reaction for early diagnosis.


Subject(s)
Mucositis/microbiology , Mycoplasma pneumoniae/isolation & purification , Stevens-Johnson Syndrome/microbiology , Stevens-Johnson Syndrome/physiopathology , Adolescent , Anti-Bacterial Agents/therapeutic use , Child , DNA, Bacterial/analysis , Follow-Up Studies , Humans , Male , Mouth Mucosa/microbiology , Mouth Mucosa/pathology , Mucositis/drug therapy , Mucositis/physiopathology , Polymerase Chain Reaction , Risk Assessment , Sampling Studies , Severity of Illness Index , Stevens-Johnson Syndrome/drug therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...